Sayone Pharmaceuticals Private Limited
About Sayone Pharmaceuticals Private Limited
Data last updated:
Sayone Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 23 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2019PTC356553. Its GSTIN is 07ABCCS8025K1Z4 (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2,000. It is led by directors Ronak Barala and Ayush Malhotra.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at U No. – 112 F/F Vardhaman Diamond Plaza Comm Center Motia Khan Pahar Ganj, New Delhi, Delhi, India – 110055.
As per the financials filed for FY 2022, the company reported a revenue of ₹33,945, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹76 (net margin -0.2%) and EBITDA of -₹60 (EBITDA margin -0.2%).
Company details
Contact details
Sayone Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressU No. – 112 F/F Vardhaman Diamond Plaza Comm Center Motia Khan Pahar Ganj, New Delhi, Delhi, India – 110055
- IndustryHealthcare, Human Health Activities
To see the full contact details of Sayone Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sayone Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sayone Pharmaceuticals Private Limited, buy the company report.
Financials of Sayone Pharmaceuticals Private Limited
FY 2022 filings availableSayone Pharmaceuticals Private Limited reported revenue of ₹33,945 (up 3068% YoY) for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹60 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹76 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.2% | ||
| Net Profit Margin | -0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sayone Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sayone Pharmaceuticals Private Limited
Sayone Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ronak Barala | Director | 23 Oct 2019 | 7 Years 0 Months | Current |
| Ayush Malhotra | Director | 24 Feb 2021 | 5 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Sayone Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sayone Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sayone Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABCCS8025K1Z4 | Delhi | Active | 21 Jul 2020 |
To see the full GST registrations and return filing status of Sayone Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sayone Pharmaceuticals Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Ayush Malhotra ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Sayone Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in human health activities, within the healthcare industry. It was incorporated on 23 October 2019 (7+ years old) and is registered under CIN U85100DL2019PTC356553.
Sayone Pharmaceuticals has 2 current directors:
- Ronak Barala - Director
- Ayush Malhotra - Director
The latest financial statements of Sayone Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sayone Pharmaceuticals is 07ABCCS8025K1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Sayone Pharmaceuticals is U85100DL2019PTC356553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sayone Pharmaceuticals was incorporated on 23 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Ayush Malhotra ceased to be Additional Director on 30 Nov 2021. Balram Kumar ceased to be Director on 25 Feb 2021. Ayush Malhotra was appointed as Director on 24 Feb 2021. Sayone Pharmaceuticals has 5 board changes on record in total.
The registered office of Sayone Pharmaceuticals is at U No. – 112 FF Vardhaman Diamond Plaza Comm Center Motia Khan Pahar Ganj, New Delhi, Delhi, India – 110055.
Sayone Pharmaceuticals operates in the healthcare industry, in the human health activities segment.
Sayone Pharmaceuticals can be reached at its registered office: U No. – 112 FF Vardhaman Diamond Plaza Comm Center Motia Khan Pahar Ganj, New Delhi, Delhi, India – 110055.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
